CD4 and prostate cancer: Lastly, unique hub-genes of naive CD4+ T-cells, such as HSPA8, are reported to be expressed in CD8+ T-cells in prostate cancer [73], while UBC, UBB, CTNNB1, and H3-3B are not reported, rendering them novel markers for naive CD4+ T-cells.